Mason RP - Search Results

1

Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET.

Swiercz R, Chiguru S, Tahmasbi A, Ramezani SM, Hao G, Challa DK, Lewis MA, Kulkarni PV, Sun X, Ober RJ, Mason RP, Ward ES. Swiercz R, et al. Among authors: mason rp. J Nucl Med. 2014 Jul;55(7):1204-7. doi: 10.2967/jnumed.113.136481. Epub 2014 May 27. J Nucl Med. 2014. PMID: 24868106 Free PMC article.

2

Fluorinated proteins as potential 19F magnetic resonance imaging and spectroscopy agents.

Mehta VD, Kulkarni PV, Mason RP, Constantinescu A, Antich PP. Mehta VD, et al. Among authors: mason rp. Bioconjug Chem. 1994 May-Jun;5(3):257-61. doi: 10.1021/bc00027a011. Bioconjug Chem. 1994. PMID: 7522583

3

6-Fluoropyridoxol: a novel probe of cellular pH using 19F NMR spectroscopy.

Mehta VD, Kulkarni PV, Mason RP, Constantinescu A, Aravind S, Goomer N, Antich PP. Mehta VD, et al. Among authors: mason rp. FEBS Lett. 1994 Aug 1;349(2):234-8. doi: 10.1016/0014-5793(94)00675-x. FEBS Lett. 1994. PMID: 8050572 Free article.

4

6-Fluoropyridoxal polymer conjugates: novel 19F pH indicators for magnetic resonance spectroscopy.

Mehta VD, Sivasubramanian A, Kulkarni PV, Mason RP, Antich PP. Mehta VD, et al. Among authors: mason rp. Bioconjug Chem. 1996 Sep-Oct;7(5):536-40. doi: 10.1021/bc9600527. Bioconjug Chem. 1996. PMID: 8889013

5

Simultaneous intracellular and extracellular pH measurement in the heart by 19F NMR of 6-fluoropyridoxol.

Hunjan S, Mason RP, Mehta VD, Kulkarni PV, Aravind S, Arora V, Antich PP. Hunjan S, et al. Among authors: mason rp. Magn Reson Med. 1998 Apr;39(4):551-6. doi: 10.1002/mrm.1910390407. Magn Reson Med. 1998. PMID: 9543416

6

Development of novel 19F NMR pH indicators: synthesis and evaluation of a series of fluorinated vitamin B6 analogues.

He S, Mason RP, Hunjan S, Mehta VD, Arora V, Katipally R, Kulkarni PV, Antich PP. He S, et al. Among authors: mason rp. Bioorg Med Chem. 1998 Sep;6(9):1631-9. doi: 10.1016/s0968-0896(98)00104-7. Bioorg Med Chem. 1998. PMID: 9801834

7

Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.

Ranney D, Antich P, Dadey E, Mason R, Kulkarni P, Singh O, Chen H, Constantanescu A, Parkey R. Ranney D, et al. J Control Release. 2005 Dec 5;109(1-3):222-35. doi: 10.1016/j.jconrel.2005.09.022. Epub 2005 Nov 14. J Control Release. 2005. PMID: 16290245

8

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.

Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N, He J, Watkins L, Kodibagkar VD, O'Kelly S, Kulkarni P, Antich PP, Hermanne A, Rösch F, Mason RP, Thorpe PE. Jennewein M, et al. Among authors: mason rp. Clin Cancer Res. 2008 Mar 1;14(5):1377-85. doi: 10.1158/1078-0432.CCR-07-1516. Clin Cancer Res. 2008. PMID: 18316558 Free PMC article.

9

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.

Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT. Xie D, et al. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2485-90. doi: 10.1073/pnas.0908133107. Epub 2010 Jan 13. Proc Natl Acad Sci U S A. 2010. PMID: 20080667 Free PMC article.

10

Multimodality imaging of hypoxia in preclinical settings.

Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK, Hao G, Thorpe P, Hahn EW, Peschke P. Mason RP, et al. Q J Nucl Med Mol Imaging. 2010 Jun;54(3):259-80. Q J Nucl Med Mol Imaging. 2010. PMID: 20639813 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

918 results

Search Page

Filters